Genetic and Antigenic Variability in VP4 and VP7 of Group A Human Rotavirus in Yunnan, China, from 2015 to 2020

Background: Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in children. There are only a few reports about the changes in prevalence and VP4/VP7 genotype of RVs in southwest China. Here is the report about the p...

Full description

Saved in:
Bibliographic Details
Published inIntervirology Vol. 68; no. 1; pp. 43 - 56
Main Authors Ma, Haoyu, Wang, Meifen, Chuan, Liufang, Long, Shuying, Qiu, Lijuan, Zhao, Canchun, Sun, Qiangming, Zhang, Zhen, Jiang, Hongchao
Format Journal Article
LanguageEnglish
Published Switzerland S. Karger AG 29.04.2025
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in children. There are only a few reports about the changes in prevalence and VP4/VP7 genotype of RVs in southwest China. Here is the report about the prevalence of RVs from 2015 to 2020 in Yunnan, southwest China. Methods: The virus genes were extracted from RV positive samples, then VP4/VP7 genes were amplified, followed by sequencing and gene typing, phylogenetic analysis, antigenic epitope variation analysis, and selective pressure analysis were also performed. Results: A total of 135 VP4 gene sequences and 143 VP7 gene sequences were obtained from stool samples during 2015–2020. Of them, P[8] genotype accounted for 97.0% of the total, while the P[4] genotype accounted for 3.0%. As for the VP7 genotype, G9 genotype accounted for 86.0% of the total, the G3 genotype accounted for 9.1%, and the G2 genotype accounted for 4.9%. G9P[8] was identified as the predominant RV strain during the epidemic season in Yunnan during 2015–2020. Phylogenetic analysis showed that G9 genotype sequences were primarily similar to African strains (KJ753473, KY661937), while P[8] genotype sequences were close to Southeast Asian strains (JQ837878, KX362594). In antigenic epitope variation analysis, among 37 epitopes of P[8] genotype, the RotaTeq™ vaccine strain covers 31 amino acid positions, Rotarix™ covers 28 amino acid positions, while LLR covers only 9. In the representative sequence of the G9 genotype, RotaTeq™ vaccine strains cover 27 out of 29 amino acid positions, Rotarix™ covers 16 positions, and LLR covers 16 positions. The results of the selective pressure analysis indicated potential positive sites for the G9P[8] genotype located at vp7-44, vp7-100, vp7-221, vp7-278, vp4-3, and vp4-4. Conclusions: Our study shows that G9P[8] is the most dominant RV genotype in Yunnan, China. Consistent with the recent epidemic trend of RV strains in China, this study could provide new perspectives on vaccine research.
AbstractList Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in children. There are only a few reports about the changes in prevalence and VP4/VP7 genotype of RVs in southwest China. Here is the report about the prevalence of RVs from 2015 to 2020 in Yunnan, southwest China. The virus genes were extracted from RV positive samples, then VP4/VP7 genes were amplified, followed by sequencing and gene typing, phylogenetic analysis, antigenic epitope variation analysis, and selective pressure analysis were also performed. A total of 135 VP4 gene sequences and 143 VP7 gene sequences were obtained from stool samples during 2015-2020. Of them, P[8] genotype accounted for 97.0% of the total, while the P[4] genotype accounted for 3.0%. As for the VP7 genotype, G9 genotype accounted for 86.0% of the total, the G3 genotype accounted for 9.1%, and the G2 genotype accounted for 4.9%. G9P[8] was identified as the predominant RV strain during the epidemic season in Yunnan during 2015-2020. Phylogenetic analysis showed that G9 genotype sequences were primarily similar to African strains (KJ753473, KY661937), while P[8] genotype sequences were close to Southeast Asian strains (JQ837878, KX362594). In antigenic epitope variation analysis, among 37 epitopes of P[8] genotype, the RotaTeq™ vaccine strain covers 31 amino acid positions, Rotarix™ covers 28 amino acid positions, while LLR covers only 9. In the representative sequence of the G9 genotype, RotaTeq™ vaccine strains cover 27 out of 29 amino acid positions, Rotarix™ covers 16 positions, and LLR covers 16 positions. The results of the selective pressure analysis indicated potential positive sites for the G9P[8] genotype located at vp7-44, vp7-100, vp7-221, vp7-278, vp4-3, and vp4-4. Our study shows that G9P[8] is the most dominant RV genotype in Yunnan, China. Consistent with the recent epidemic trend of RV strains in China, this study could provide new perspectives on vaccine research.
Background: Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in children. There are only a few reports about the changes in prevalence and VP4/VP7 genotype of RVs in southwest China. Here is the report about the prevalence of RVs from 2015 to 2020 in Yunnan, southwest China. Methods: The virus genes were extracted from RV positive samples, then VP4/VP7 genes were amplified, followed by sequencing and gene typing, phylogenetic analysis, antigenic epitope variation analysis, and selective pressure analysis were also performed. Results: A total of 135 VP4 gene sequences and 143 VP7 gene sequences were obtained from stool samples during 2015–2020. Of them, P[8] genotype accounted for 97.0% of the total, while the P[4] genotype accounted for 3.0%. As for the VP7 genotype, G9 genotype accounted for 86.0% of the total, the G3 genotype accounted for 9.1%, and the G2 genotype accounted for 4.9%. G9P[8] was identified as the predominant RV strain during the epidemic season in Yunnan during 2015–2020. Phylogenetic analysis showed that G9 genotype sequences were primarily similar to African strains (KJ753473, KY661937), while P[8] genotype sequences were close to Southeast Asian strains (JQ837878, KX362594). In antigenic epitope variation analysis, among 37 epitopes of P[8] genotype, the RotaTeq™ vaccine strain covers 31 amino acid positions, Rotarix™ covers 28 amino acid positions, while LLR covers only 9. In the representative sequence of the G9 genotype, RotaTeq™ vaccine strains cover 27 out of 29 amino acid positions, Rotarix™ covers 16 positions, and LLR covers 16 positions. The results of the selective pressure analysis indicated potential positive sites for the G9P[8] genotype located at vp7-44, vp7-100, vp7-221, vp7-278, vp4-3, and vp4-4. Conclusions: Our study shows that G9P[8] is the most dominant RV genotype in Yunnan, China. Consistent with the recent epidemic trend of RV strains in China, this study could provide new perspectives on vaccine research.
Rotavirus(RVs) A is one of major reasons which causes severe dehydration diarrhea. It is also one of the high morbidity disease in children. There are only a few reports about the changes in prevalence and VP4 / VP7 genotype of RVs in southwest China.Here is the report about the prevalence of RV from 2015 to 2020 in Yunnan, southwest China.BACKGROUNDRotavirus(RVs) A is one of major reasons which causes severe dehydration diarrhea. It is also one of the high morbidity disease in children. There are only a few reports about the changes in prevalence and VP4 / VP7 genotype of RVs in southwest China.Here is the report about the prevalence of RV from 2015 to 2020 in Yunnan, southwest China.The virus genes were extracted from RV positive samples, then VP4/VP7 genes were amplified, followed by sequencing and Gene typing, Phylogenetic analysis, antigenic epitope variation analysis and selective pressure analysis were also performed.METHODSThe virus genes were extracted from RV positive samples, then VP4/VP7 genes were amplified, followed by sequencing and Gene typing, Phylogenetic analysis, antigenic epitope variation analysis and selective pressure analysis were also performed.135 VP4 gene sequences and 143 VP7 gene sequences were obtained from stool samples during 2015 to 2020. Of them, P[8] genotype accounted for 97.0% of total, while the P[4] genotype accounted for 3.0%. As for the VP7 genotype, G9 genotype accounted for 86.0% of total, the G3 genotype accounted for 9.1%, and the G2 genotype accounted for 4.9%. G9P[8] was identified as the predominant RV strain during the epidemic season in Yunnan during 2015 to 2020. Phylogenetic analysis showed that G9 genotype sequences were primarily similar to African strains (KJ753473, KY661937), while P[8] genotype sequences were close to Southeast Asian strains (JQ837878, KX362594). In antigenic epitope variation analysis, among 37 epitope of P[8] genotype, the RotaTeq™ vaccine strain covers 31 amino acid positions, Rotarix™ covers 28 amino acid positions, while LLR covers only 9. In the representative sequence of the G9 genotype, RotaTeq™ vaccine strains cover 27 out of 29 amino acid positions, Rotarix™ cover 16 positions, and LLR cover 16 positions. The results of the selective pressure analysis indicated potential positive sites for the G9P[8] genotype located at vp7-44, vp7-100, vp7-221, vp7-278, vp4-3 and vp4-4.RESULTS135 VP4 gene sequences and 143 VP7 gene sequences were obtained from stool samples during 2015 to 2020. Of them, P[8] genotype accounted for 97.0% of total, while the P[4] genotype accounted for 3.0%. As for the VP7 genotype, G9 genotype accounted for 86.0% of total, the G3 genotype accounted for 9.1%, and the G2 genotype accounted for 4.9%. G9P[8] was identified as the predominant RV strain during the epidemic season in Yunnan during 2015 to 2020. Phylogenetic analysis showed that G9 genotype sequences were primarily similar to African strains (KJ753473, KY661937), while P[8] genotype sequences were close to Southeast Asian strains (JQ837878, KX362594). In antigenic epitope variation analysis, among 37 epitope of P[8] genotype, the RotaTeq™ vaccine strain covers 31 amino acid positions, Rotarix™ covers 28 amino acid positions, while LLR covers only 9. In the representative sequence of the G9 genotype, RotaTeq™ vaccine strains cover 27 out of 29 amino acid positions, Rotarix™ cover 16 positions, and LLR cover 16 positions. The results of the selective pressure analysis indicated potential positive sites for the G9P[8] genotype located at vp7-44, vp7-100, vp7-221, vp7-278, vp4-3 and vp4-4.Our study shows that G9P [8] is the most dominant rotavirus genotype in Yunnan China. Consistent with the recent epidemic trend of RV strains in China, this study could provide new perspectives on vaccine research.CONCLUSIONSOur study shows that G9P [8] is the most dominant rotavirus genotype in Yunnan China. Consistent with the recent epidemic trend of RV strains in China, this study could provide new perspectives on vaccine research.
Author Qiu, Lijuan
Ma, Haoyu
Long, Shuying
Jiang, Hongchao
Chuan, Liufang
Zhao, Canchun
Zhang, Zhen
Sun, Qiangming
Wang, Meifen
Author_xml – sequence: 1
  givenname: Haoyu
  surname: Ma
  fullname: Ma, Haoyu
– sequence: 2
  givenname: Meifen
  surname: Wang
  fullname: Wang, Meifen
– sequence: 3
  givenname: Liufang
  surname: Chuan
  fullname: Chuan, Liufang
– sequence: 4
  givenname: Shuying
  surname: Long
  fullname: Long, Shuying
– sequence: 5
  givenname: Lijuan
  surname: Qiu
  fullname: Qiu, Lijuan
– sequence: 6
  givenname: Canchun
  surname: Zhao
  fullname: Zhao, Canchun
– sequence: 7
  givenname: Qiangming
  surname: Sun
  fullname: Sun, Qiangming
– sequence: 8
  givenname: Zhen
  surname: Zhang
  fullname: Zhang, Zhen
– sequence: 9
  givenname: Hongchao
  surname: Jiang
  fullname: Jiang, Hongchao
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40300562$$D View this record in MEDLINE/PubMed
BookMark eNpVkV1r2zAYhUVpWdNsF_0DRZcr1Ks-LNm-GiG06aDQUtZAr8RrWUo0bCmT7ED-fZ1-hO3q8PI-nAPnnKFjH7xB6JySH5SK6poQInJJpDhCE5oznhFKyDGaEE5IJgSTp-gspT8jxiknX9Bpvv8IySYoLIw3vdMYfINnvncr48drCdFB7VrX77DzePmYvwHLxwIHixcxDBs8w3dDBx4_hR62Lg5pT74M3oO_wvO183CFbQwdZoQK3IdRGfmKTiy0yXz70Cl6vr35Pb_L7h8Wv-az-0xzXvYZrWxZ2kZWumS8gFJI2RjLwMq6ZFSaugYtRMFtYyrBQOtScgnMNlA0wrCcT9HPd9_NUHem0cb3EVq1ia6DuFMBnPr_491arcJWUTYGsjF1ir5_OMTwdzCpV51L2rQteBOGpDitCjkWKeSIXvwbdkj5rHkELt8BHUNK0dgDQonaT6gOE_JXt7aKvA
Cites_doi 10.3390/vaccines8030341
10.1186/s12879-022-07542-9
10.1186/s12879-021-05795-4
10.1016/j.vaccine.2018.08.081
10.1097/00006454-198603000-00012
10.1002/jmv.27806
10.2807/1560-7917.ES.2019.24.15.1800418
10.1136/archdischild-2017-313163
10.1002/jmv.25214
10.1016/j.vaccine.2018.08.046
10.3201/eid2803.212117
10.1093/jpids/piw071
10.1016/j.vaccine.2019.03.069
10.1007/s44197-022-00050-8
10.1016/j.jinf.2015.03.001
10.1186/s12879-020-05279-x
10.1016/j.cmi.2016.06.007
10.1080/21645515.2020.1801071
10.4415/ANN_13_02_03
10.1590/0037-8682-0023-2015
10.1093/cid/ciy1096
10.11604/PAMJ.SUPP.2017.28.1.2486
10.1002/rmv.2020
10.1186/s12929-020-00649-8
10.1016/j.lanwpc.2021.100268
10.1136/BMJ-2021-066169
10.4269/ajtmh.18-0763
10.1186/s12879-018-3411-3
10.1371/journal.pone.0242813
10.1007/s00705-023-05849-9
10.1186/s12879-020-05448-y
10.1099/jgv.0.000807
10.1186/s12879-020-05230-0
10.1016/j.vaccine.2018.05.031
10.1017/S0950268820002320
10.2807/1560-7917.ES.2019.24.6.1700774
10.1016/j.vaccine.2014.06.018
10.1016/j.cmi.2017.10.009
10.1002/jmv.25530
10.3390/tropicalmed8020101
10.1007/s00705-013-1663-1
10.1016/j.jinf.2021.09.007
10.1186/s12879-020-05718-9
10.1002/jmv.25067
10.1053/j.spid.2006.08.005
10.1007/s12250-018-0043-0
10.1016/j.heliyon.2023.e18236
10.7717/peerj.10954
10.3390/ijms241512189
10.1016/j.vaccine.2019.09.022
10.1186/s12889-019-6406-0
10.1016/j.jes.2017.07.015
10.1128/JVI.02076-17
10.1002/ece3.5015
10.2165/11207130-000000000-00000
10.1001/jamapediatrics.2018.1960
10.1073/pnas.2013182117
ContentType Journal Article
Copyright 2025 The Author(s). Published by S. Karger AG, Basel.
The Author(s). Published by S. Karger AG, Basel.
2025 The Author(s). Published by S. Karger AG, Basel 2025
Copyright_xml – notice: 2025 The Author(s). Published by S. Karger AG, Basel.
– notice: The Author(s). Published by S. Karger AG, Basel.
– notice: 2025 The Author(s). Published by S. Karger AG, Basel 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1159/000546065
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Prevalence of RV from 2015 to 2020 in Yunnan
EISSN 1423-0100
EndPage 56
ExternalDocumentID PMC12237282
40300562
10_1159_000546065
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
-~X
0~B
326
36B
3O.
4.4
5GY
5RE
AAYIC
AAYXX
ABBTS
ABPAZ
ABWCG
ACGFS
ACGOD
ACPRK
ACPSR
ADBBV
ADFRT
AENEX
AEYAO
AHFRZ
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZPMC
BENPR
CITATION
CS3
DU5
E0A
EBS
EMB
EMOBN
F5P
FB.
GROUPED_DOAJ
HCIFZ
HZ~
IAO
IY7
KUZGX
L7B
M--
M7P
N9A
O1H
O9-
OK1
RKO
SV3
UJ6
.GJ
0~5
29J
30W
34G
39C
3O-
53G
7X7
88E
88I
8AF
8AO
8FE
8FH
8FI
8FJ
8UI
ABJNI
ABUWG
ACQXL
ADAGL
AFFNX
AFJJK
AFKRA
AFSIO
AI.
AIOBO
AZQEC
BBNVY
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CUY
CVF
CYUIP
DWQXO
ECM
EIF
EJD
FYUFA
GNUQQ
HMCUK
IHR
INH
ITC
LK8
M1P
M2P
NPM
OHT
PHGZM
PHGZT
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
RIG
RXVBD
S0X
UKHRP
VH1
ZGI
ZXP
7X8
5PM
ID FETCH-LOGICAL-c338t-19f88fd69c8237a8566def2af6b8216ebbac5573fde952acc8636a2fda7d5e243
ISSN 0300-5526
1423-0100
IngestDate Thu Aug 21 18:23:29 EDT 2025
Thu May 01 02:03:17 EDT 2025
Sat Jul 12 02:48:56 EDT 2025
Wed Jul 16 16:36:01 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Phylogenetic analysis
Prevalence
Rotavirus A
Antigen epitope variation
Language English
License https://creativecommons.org/licenses/by-nc/4.0
2025 The Author(s). Published by S. Karger AG, Basel.
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c338t-19f88fd69c8237a8566def2af6b8216ebbac5573fde952acc8636a2fda7d5e243
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Haoyu Ma and Meifen Wang contributed equally to this article.
OpenAccessLink http://dx.doi.org/10.1159/000546065
PMID 40300562
PQID 3197640356
PQPubID 23479
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_12237282
proquest_miscellaneous_3197640356
pubmed_primary_40300562
crossref_primary_10_1159_000546065
PublicationCentury 2000
PublicationDate 2025-04-29
PublicationDateYYYYMMDD 2025-04-29
PublicationDate_xml – month: 04
  year: 2025
  text: 2025-04-29
  day: 29
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel, Switzerland
PublicationTitle Intervirology
PublicationTitleAlternate Intervirology
PublicationYear 2025
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References ref13
ref57
ref12
ref56
ref15
ref14
ref53
ref52
ref11
ref55
ref10
ref54
ref17
ref16
ref19
ref18
ref51
ref50
ref46
ref45
ref48
ref47
ref42
ref41
ref44
ref43
ref49
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref40
ref35
ref34
ref37
ref36
ref31
ref30
ref33
ref32
ref2
ref1
ref39
ref38
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
References_xml – ident: ref2
  doi: 10.3390/vaccines8030341
– ident: ref55
  doi: 10.1186/s12879-022-07542-9
– ident: ref17
  doi: 10.1186/s12879-021-05795-4
– ident: ref46
  doi: 10.1016/j.vaccine.2018.08.081
– ident: ref28
  doi: 10.1097/00006454-198603000-00012
– ident: ref23
  doi: 10.1002/jmv.27806
– ident: ref32
  doi: 10.2807/1560-7917.ES.2019.24.15.1800418
– ident: ref4
  doi: 10.1136/archdischild-2017-313163
– ident: ref51
  doi: 10.1002/jmv.25214
– ident: ref39
  doi: 10.1016/j.vaccine.2018.08.046
– ident: ref24
  doi: 10.3201/eid2803.212117
– ident: ref3
  doi: 10.1093/jpids/piw071
– ident: ref9
  doi: 10.1016/j.vaccine.2019.03.069
– ident: ref25
  doi: 10.1007/s44197-022-00050-8
– ident: ref20
  doi: 10.1016/j.jinf.2015.03.001
– ident: ref45
  doi: 10.1186/s12879-020-05279-x
– ident: ref11
  doi: 10.1016/j.cmi.2016.06.007
– ident: ref6
  doi: 10.1080/21645515.2020.1801071
– ident: ref30
  doi: 10.4415/ANN_13_02_03
– ident: ref5
  doi: 10.1590/0037-8682-0023-2015
– ident: ref38
  doi: 10.1093/cid/ciy1096
– ident: ref48
  doi: 10.11604/PAMJ.SUPP.2017.28.1.2486
– ident: ref16
  doi: 10.1002/rmv.2020
– ident: ref52
  doi: 10.1186/s12929-020-00649-8
– ident: ref21
  doi: 10.1016/j.lanwpc.2021.100268
– ident: ref26
  doi: 10.1136/BMJ-2021-066169
– ident: ref15
  doi: 10.4269/ajtmh.18-0763
– ident: ref18
  doi: 10.1186/s12879-018-3411-3
– ident: ref14
  doi: 10.1371/journal.pone.0242813
– ident: ref56
  doi: 10.1007/s00705-023-05849-9
– ident: ref42
  doi: 10.1186/s12879-020-05448-y
– ident: ref44
  doi: 10.1099/jgv.0.000807
– ident: ref34
  doi: 10.1186/s12879-020-05230-0
– ident: ref40
  doi: 10.1016/j.vaccine.2018.05.031
– ident: ref37
  doi: 10.1017/S0950268820002320
– ident: ref31
  doi: 10.2807/1560-7917.ES.2019.24.6.1700774
– ident: ref49
  doi: 10.1016/j.vaccine.2014.06.018
– ident: ref33
  doi: 10.1016/j.cmi.2017.10.009
– ident: ref19
  doi: 10.1002/jmv.25530
– ident: ref53
  doi: 10.3390/tropicalmed8020101
– ident: ref50
  doi: 10.1007/s00705-013-1663-1
– ident: ref22
  doi: 10.1016/j.jinf.2021.09.007
– ident: ref36
  doi: 10.1186/s12879-020-05718-9
– ident: ref41
  doi: 10.1002/jmv.25067
– ident: ref8
  doi: 10.1053/j.spid.2006.08.005
– ident: ref47
  doi: 10.1007/s12250-018-0043-0
– ident: ref57
  doi: 10.1016/j.heliyon.2023.e18236
– ident: ref43
  doi: 10.7717/peerj.10954
– ident: ref54
  doi: 10.3390/ijms241512189
– ident: ref35
  doi: 10.1016/j.vaccine.2019.09.022
– ident: ref13
  doi: 10.1186/s12889-019-6406-0
– ident: ref29
  doi: 10.1016/j.jes.2017.07.015
– ident: ref10
  doi: 10.1128/JVI.02076-17
– ident: ref12
  doi: 10.1002/ece3.5015
– ident: ref7
  doi: 10.2165/11207130-000000000-00000
– ident: ref1
  doi: 10.1001/jamapediatrics.2018.1960
– ident: ref27
  doi: 10.1073/pnas.2013182117
SSID ssj0003130
Score 2.3938034
Snippet Background: Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in...
Rotavirus (RV) A is one of the major reasons which causes acute dehydration and diarrhea. It is also one of the highest morbid diseases in children. There are...
Rotavirus(RVs) A is one of major reasons which causes severe dehydration diarrhea. It is also one of the high morbidity disease in children. There are only a...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 43
SubjectTerms Antigenic Variation
Antigens, Viral - genetics
Antigens, Viral - immunology
Capsid Proteins - genetics
Capsid Proteins - immunology
Child, Preschool
China - epidemiology
Epitopes - genetics
Feces - virology
Genetic Variation
Genotype
Humans
Infant
Phylogeny
Prevalence
Rotavirus - classification
Rotavirus - genetics
Rotavirus - immunology
Rotavirus - isolation & purification
Rotavirus Infections - epidemiology
Rotavirus Infections - virology
Sequence Analysis, DNA
Title Genetic and Antigenic Variability in VP4 and VP7 of Group A Human Rotavirus in Yunnan, China, from 2015 to 2020
URI https://www.ncbi.nlm.nih.gov/pubmed/40300562
https://www.proquest.com/docview/3197640356
https://pubmed.ncbi.nlm.nih.gov/PMC12237282
Volume 68
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiQuiDflJYM4biBxbMc5VitQhVS0ErvVcoocx1ZzSdCSrNS98c8ZP5KmWw4Ll6hN7aT1fJ1XZj4j9CGvuMq1pcfTkkfUKBVJo3hUpSbLlGGUK5vvWH3jy3P69YJdzGa_p90lXflRXf-1r-R_pArnQK62S_YfJDteFE7Aa5AvHEHCcLyVjC1n9EC4umg6S6wJ79YQ_nr2bdfTtz6lbsD6NLOeoc8-LYbsfdvJq_qyd1WxP8CZleEhfO17xVz3CVhvZn1UEpN46sy6bKLtk5tm5ldu3lK2236XrPcKZaVrs-s8O9n0oe-h7o0MBtSWBoUi4e-bfjvY1ZCWIMw-YQm5i9COFccRYyTwXHvtCr5bBAFgPFW_XBzAzOtST98UrLJnHz_U9yz3BZIAqthvOrHPqX3D1o0ViC72YXkxTr2D7hKINMgQlQdjniZuu5rx1wRyKpj6aZy679IcxCk3y20n_svZQ_QgBB544VH0CM108xjd81uRbp-gNmAJA1TwiCU8wRKuGwxYcgMAS7g12GEJL7DDEh6xZEd6LB1jh6RjbHGELY5w12KLo6fo_Mvns5NlFDbjiFSaii5KciOEqXiuLL2RFBAGVNoQaXgpSMJ1WUrFWJaaSueMSKUET7kkppJZxTSh6TN01LSNfoHgLrGCpSSUaUEp-JhGsbiiCTHSbpCm5-j9sJ7FT8-5UhzIa47eDStdgEa0j7lko9v-VwFGJeM0Thmfo-d-5cfLUCtIcPnnSOzJZBxg2db3P2nqjWNdT8CRzoggL2_z7V6h-7s_xWt01F32-g14r1351uHrD8VvlEo
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+and+Antigenic+Variability+in+VP4+and+VP7+of+Group+A+Human+Rotavirus+in+Yunnan%2C+China%2C+from+2015+to+2020&rft.jtitle=Intervirology&rft.au=Ma%2C+Haoyu&rft.au=Wang%2C+Meifen&rft.au=Chuan%2C+Liufang&rft.au=Long%2C+Shuying&rft.date=2025-04-29&rft.issn=0300-5526&rft.eissn=1423-0100&rft.volume=68&rft.issue=1&rft.spage=43&rft.epage=56&rft_id=info:doi/10.1159%2F000546065&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000546065
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-5526&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-5526&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-5526&client=summon